North Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
North Capital's MRK Position: Q3 2026 in Review
North Capital reduced its Merck (MRK) stake by 1.8% in Q3 2026, selling an estimated $7.46K and leaving 2,903 shares worth $412K. The position accounts for 0.29% of the portfolio, ranked #50.
North Capital first reported a position in MRK in Q1 2025 and has held it in 7 quarters since. 1,705 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- North Capital held 2,903 shares of Merck worth $412K as of Q3 2026.
- North Capital sold 54 Merck shares in Q3 2026, an estimated $7.46K.
- Merck made up 0.29% of North Capital's portfolio in Q3 2026, its #50 holding.
- North Capital first reported a position in Merck in Q1 2025 and has held it in 7 quarters since.
- 1,705 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on North Capital's 13F filing for Q3 2026, filed 16 Oct 2026.